1-3 of 3
Elizabeth S. Klings
Close
Sort by
Journal Articles

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection

Clinical Trials & Observations
Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, Michael U. Callaghan, Sarah Carpenter, Charleen Jacobs, Jin Han, Jena Simon, Jeffrey Glassberg, Victor R. Gordeuk, Elizabeth S. Klings
Journal: Blood Advances
Blood Adv (2021) 5 (1): 207–215.
https://doi.org/10.1182/bloodadvances.2020003456
Published: 2021
Includes: Supplemental data
Journal Articles

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

Ann T. Farrell, Julie Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey Lebensburger, Mark C. Walters, Daniel E. Bauer, Rae M. Blaylark, Donna M. DiMichele, Mark T. Gladwin, Nancy S. Green, Kathryn Hassell, Gregory J. Kato, Elizabeth S. Klings, Donald B. Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T. McGann, Caterina Minniti, Claudia R. Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4002–4020.
https://doi.org/10.1182/bloodadvances.2019000883
Published: 2019
Includes: Supplemental data
Journal Articles

Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections

James R. Eckman, Kathryn L. Hassell, Wayne Huggins, Ellen M. Werner, Elizabeth S. Klings, Robert J. Adams, Julie A. Panepinto, Carol M. Hamilton
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2703–2711.
https://doi.org/10.1182/bloodadvances.2017010702
Published: 2017